Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.

Feitong LeiMichelle R LofwallPatricia R FreemanEmily SladeRachel Vickers-SmithSvetla Slavova

Published in: The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association (2022)

Transmucosal buprenorphine utilization increased during the COVID-19 pandemic after experiencing interruption during the initial weeks of the pandemic. Future studies should evaluate the contribution of the relaxed telemedicine buprenorphine prescribing regulations during the COVID-19 national emergency on initiation and maintenance of buprenorphine treatment.

Keyphrases

coronavirus disease
sars cov
primary care
emergency department
healthcare
combination therapy
quality improvement
electronic health record